CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Executive or director change · Other events
- 4 Other acquisition Director acquired 1,791,549 shares (other)
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
Page 15 of 19 · 362 filings